, and small cell lung carcinomas (Johnson et al., 1988) . Moreover, specific chromosome abnormalities have also been found in a number of human cancers (Yokota et al., 1987; Baker et al., 1989; Lee et al., 1989) . However, activation of proto-oncogenes in gastric carcinomas is low compared to colonic and pancreatic carcinomas (Forrester et al., 1987; Smit et al., 1988) .
Recent evidence indicates that amplification of specific oncogenes is correlated with tumour stage and prognosis of neuroblastomas (Tsuda et al., 1988a) , breast carcinomas (Slamon et al., 1987; Varley et al., 1987) , and small cell lung carcinomas (Johnson et al., 1988) . Moreover, specific chromosome abnormalities have also been found in a number of human cancers (Yokota et al., 1987; Baker et al., 1989; Lee et al., 1989) . However, activation of proto-oncogenes in gastric carcinomas is low compared to colonic and pancreatic carcinomas (Forrester et al., 1987; Smit et al., 1988) .
Loss of chromosomal heterozygosity is also infrequently found in gastric carcinomas even at chromosomal loci frequently deleted in other tumours, and little is known about genetic changes that are associated with metastasis of gastric carcinomas. We have demonstrated previously that amplification of ERBB and ERBB2 genes is detected in 2.7% and 5.4% of primary gastric carcinomas, respectively (Yoshida et al., 1989) . To ascertain whether alteration of oncogene plays an important role in tumour progression and metastasis, Southern blot analyses were conducted on DNAs extracted from samples of early, advanced and metastatic human gastric carcinomas. Southern blot analysis High molecular weight DNAs were prepared using the phenol-chloroform method after treatment with sodium dodecyl sulphate (SDS) and proteinase K. DNAs were digested with EcoRI or BamHI, and 10 iLg of completely digested DNAs was electrophoresis on 0.8% agarose gel. After electrophoresis, DNAs were denatured, neutralised and transferred to nitrocellulose filters according to the method of Southern (Southern, 1975) . The filters were hybridised under stringent conditions with 32P-labelled probes. After hybridisation, filters were washed and exposed to Kodak XAR-5 films. The same filters were hybridised repeatedly with probes for several oncogenes to exclude the possibility that the difference in the intensities of the bands in different lanes was due to difference in the amounts of DNAs loaded on agarose gels. The levels of amplification were determined by densitometry and the sum of the densitometric signals of all the bands was taken.
Materials and methods

Tissues
Slot blot analysis DNAs were extracted from formalin-fixed and paraffinembedded tissues of 20 early gastric carcinomas and one advanced gastric carcinoma whose metastatic tumours had amplification of ERBB2, HST1, and INT2 genes. Sections of 20 Itm in thickness were cut from the blocks using a microtome and these sections were collected. DNAs were extracted following the methods of Goelz et al. (1985) or Dubeau et al. (1986) . Ten ILg of the DNA was dissolved in 0.4 M sodium hydroxide, and TE (10 mM tris hydroxymethyl aminomethane and 1 mM ethylene diaminetetraacetic acid (EDTA) pH 7.4) was added to make 50 pAl of the solution. The samples were incubated for 10 minutes at 37°C, treated with an equal volume of 2 M ammonium acetate and applied to a nitrocellulose filter. Filters were baked at 80°C for 2 hours under vacuum. The procedure of hybridisation was the same as that of Southern blot analysis as described above.
DNA probes Probe C, a 0.79 kbp EcoRI-EcoRI fragment of the HST1 gene was kindly provided by Dr Sakamoto (Sakamoto et al., 1986 (Yoshida et al., 1989) . In this study we examined 38 additional cases of advanced gastric carcinoma, including 32 fresh samples of surgical cases, one paraffin-embedded tissue of a surgical case and 5 fresh samples of autopsy cases. We found two cases of ERBB2 amplification, i.e. autopsy case 9 (Figure lb) and case 5 of paraffin embedded surgical case (Figure 3) . Therefore, the frequency of ERBB and ERBB2 gene amplification in primary tumours was one (1.4%) and 4 (5.8%) out of 69 primary tumours, respectively. Slot blot analyses Figure 3 shows the results of slot blot analyses in primary tumour of case 5 which showed metastatic tumours with coamplification of ERBB2, HST1, and INT2 genes ( Figure  2 In the present study, the frequency of ERBB and ERBB2 gene amplification in metastatic gastric carcinomas of autopsy cases was 9.4% and 25.0%, respectively, which was evidently higher than that of advanced primary carcinomas. Moreover, we did not detect amplification of these genes in early gastric carcinomas (Table II) . These results strongly indicate that amplification of ERBB and ERBB2 genes might occur during the course of progression and metastasis. ERBB2 gene amplification is well known to occur selectively in tubular adenocarcinoma of the stomach (Yokota et al., 1988a) . However, in the present study, ERBB2 gene was amplified not only in well differentiated tubular adenocarcinoma, but also in poorly differentiated adenocarcinoma or signet ring cell carcinoma of metastatic tumours. In addition, metastatic tumours were associated with multiple alterations of oncogenes. To our knowledge, they are the first reports showing ERBB amplification and LMYC deletion, or ERBB2, INT2 and HST1 gene coamplification in metastatic tumours of gastric carcinoma.
The LMYC gene maps to chromosome 1 at band p32, and this locus is frequently lost in endocrine neoplasia (Mathew et al., 1987) . Loss of heterozygosity (LOH) on chromosome lp has been observed in two of 12 gastric carcinomas in surgical cases (Wada et al., 1988) . In the present study, allelic deletion of LMYC gene was detected in three of 32 metastatic tumours, and its incidence was almost the same as that of LOH of chromosome lp reported by Wada et al. (1988) . However, Fey et al. (1989) recently reported that other loci such as chromosome 1 at band q21-24 and chromosome 12 at band q24 were frequently lost in gastric carcinomas. Further investigations of LOH are necessary to determine any correlation between LOH and incidence of gastric carcinomas.
The HST1 gene, first isolated from gastric carcinoma by NIH3T3 transfection assay, is frequently amplified in squamous cell carcinoma of the oesophagus or head and neck, and is usually associated with INT2 gene amplification, because these two genes are mapped to the same loci of chromosome 11 at band q13 (Wada et al., 1989) . We have detected HST1 and INT2 gene coamplification in 50% of primary tumours and all of the metastatic tumours of oesophageal squamous cell carcinomas. However, this could not be detected in primary gastric carcinomas (Tsuda et al., 1988b . Interestingly, we detected HST1 and INT2 coamplification in three metastatic tumours of a gastric carcinoma with amplified ERBB2 genes. Moreover, the primary tumour of this case had no amplification of HST1 and INT2 genes, whereas ERBB2 gene was amplified.
There are two possible explanations for the discrepancy of oncogene amplification between primary and metastatic tumours. One is that primary tumour contained a small fraction of the cells with amplified sequence of oncogenes which had selective advantage to progression or metastasis (Yokota et al., 1988b; Wahl, 1989) . The other is that the oncogene amplification was not an initiating event of carcinogenesis, and they occurred as the results of response to tumour progression and metastasis (Alitalo, 1987; Yokota et al., 1988b) . It is very difficult to conclude at present whether amplification contributes to metastasis or is the result of response to other events. However, recent evidence indicates that other oncogene alterations and inactivation of tumour suppresser genes are detected in the early stages of carcinoma development. In colorectal carcinoma, point mutation of ras gene and LOH of chromosome 5 occur in the early stage of tumour or adenoma, and LOH of chromosome 17, 18 occurs in advanced tumours (Vogelstein et al., 1988) . In lung carcinomas, LOH of 3, 13 and 17 is found in the early stage of tumours and amplification of myc family gene is detected in advanced carcinomas (Yokota et al., 1987 (Yokota et al., , 1988b . These results support the hypothesis of multistep carcinogenesis including mutation as the first step, loss of heterozygosity at the second step, and oncogene amplification at the final step (Land et al., 1983; Barbacid, 1987; Nicolson et al., 1987; Yokota et al., 1987 Yokota et al., , 1988b Green, 1988) . Moreover, our recent results indicate that overexpression of several tumour autocrine growth factors in primary tumours occurs regardless of gene amplifications (Yoshida et al., 1990a,b) . Marco et al. (1989) also demonstrated the important role of TGF-a and EGFR on the cell transformation. These results suggest that hyperproduction of growth factor by tumour cells may occur before gene amplification. At the terminal stage of gastric carcinoma with high malignant condition, hyperproduction of tumour autocrine growth factors might result in multisite metastases, leading to amplification of oncogenes.
